Neurocrine Bioscience buy Piper Sandler
Start price
06.05.25
/
50%
€105.90
Target price
06.05.26
€136.35
Performance (%)
22.90%
Price
12.12.25
€130.15
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler currently has a performance of 22.90%. This prediction currently runs until 06.05.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Piper_Sandler for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $154.00 price target on the stock, down previously from $160.00.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€153.67
29.10.26
29.10.26
10.44%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€153.09
31.07.26
31.07.26
12.93%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€130.60
23.12.24
23.12.24
€153.97
23.12.25
23.12.25
-0.34%
12.12.25
12.12.25